Sheremata noted that the objective measures in the study did not show any benefit from marijuana. "Those are the only valid measures. Subjective responses are subjective; they really don't have much in the way of validity," he said. "I am not convinced that the use of marijuana benefits patients as a whole."
For more information on multiple sclerosis, visit the National Multiple Sclerosis Society.
Copyright © 2011 HealthDay. All rights reserved.